Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Kubilay Tolunay P"'
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-12 (2024)
Abstract Background This study aimed to establish risk groups on the basis of CPS-EG scores, independent of pCR status, in triple-negative breast cancer (TNBC) patients receiving neoadjuvant chemotherapy (NACT) to identify the prognostic impact of th
Externí odkaz:
https://doaj.org/article/6f27287556b24ac09fa0b818fc18e00c
Autor:
Bediz Kurt İnci, Pınar Kubilay Tolunay, Şura Öztekin, Ergin Aydemir, İrem Öner, Öztürk Ateş, Cengiz Karaçin
Publikováno v:
Current Oncology, Vol 31, Iss 10, Pp 5722-5729 (2024)
Background: Currently, the combination of cyclin-dependent kinase 4/6 (CDK4/6) inhibitors and endocrine therapy is a first-line treatment for hormone-receptor-positive and HER2-negative metastatic breast cancer. This study aimed to assess the impact
Externí odkaz:
https://doaj.org/article/a433ba64f8604e4fafa1869340c79037
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Bas, O., Inci, B.K., Eroglu, I., Efil, S.C., Kaya, S., Kubilay Tolunay, P., Karacin, C., Yazici, O., Sendur, M.A.N., Oksuzoglu, B.O., Aksoy, S.
Publikováno v:
In Annals of Oncology September 2024 35 Supplement 2:S1099-S1099
Autor:
GÜRBÜZ, Mustafa, DOĞAN, İzzet, AKKUŞ, Erman, ÖZAKINCI, Hilal, KUBİLAY TOLUNAY, Pınar, KALACI, Ender, BAĞLAN, Tolga, KÖKSOY, Elif Berna, CEYHAN, Koray, DİZBAY SAK, Serpil, AYDINER, Adnan, DEMİRKAZIK, Ahmet, UTKAN, Güngör
Publikováno v:
Tuberculosis & Thorax / Tuberkoloz ve Toraks; Jun2022, Vol. 70 Issue 2, p132-140, 9p
Autor:
Kubilay Tolunay, Pinar, Erol, Cihan, Kahraman, Seda, Tacar, Seher Yildiz, Özcan, Erkan, Basal, Fatma Bugdayci, Köse, Fatih, Sendur, Mehmet A.N., Tural, Deniz, Cicin, Irfan, Oksuzoglu, Berna, Ürün, Yüksel
Publikováno v:
Journal of Clinical Oncology; 2023 Supplement 16, Vol. 41, pe18904-e18904, 1p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Gürbüz M; Division of Medical Oncology, Ankara University Faculty of Medicine, Ankara, Turkey., Doğan İ; Division of Medical Oncology, İstanbul University Faculty of Medicine, İstanbul, Turkey., Akkuş E; Department of Internal Medicine, Ankara University Faculty of Medicine, Ankara, Turkey., Özakıncı H; Department of Pathology, Ankara University Faculty of Medicine, Ankara, Turkey., Kubilay Tolunay P; Division of Medical Oncology, Ankara University Faculty of Medicine, Ankara, Turkey., Kalacı E; Division of Medical Oncology, Ankara University Faculty of Medicine, Ankara, Turkey., Bağlan T; Department of Pathology, Ankara University Faculty of Medicine, Ankara, Turkey., Köksoy EB; Division of Medical Oncology, Ankara University Faculty of Medicine, Ankara, Turkey., Ceyhan K; Department of Pathology, Ankara University Faculty of Medicine, Ankara, Turkey., Dizbay Sak S; Department of Pathology, Ankara University Faculty of Medicine, Ankara, Turkey., Aydıner A; Division of Medical Oncology, İstanbul University Faculty of Medicine, İstanbul, Turkey., Demirkazık A; Division of Medical Oncology, Ankara University Faculty of Medicine, Ankara, Turkey., Utkan G; Division of Medical Oncology, Ankara University Faculty of Medicine, Ankara, Turkey.
Publikováno v:
Tuberkuloz ve toraks [Tuberk Toraks] 2022 Jun; Vol. 70 (2), pp. 132-140.